Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0000950170-23-060611

Options or other derivatives

  • Chief Scientific Officer acquired 86,374 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Colletti Steve · Chief Scientific Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-11-03 Grant or award : show line 1 in the form Stock Option (Right to Buy) +51,896 51,896 D
2023-11-03 Grant or award : show line 2 in the form Stock Option (Right to Buy) +34,478 34,478 D
Loading xslF345X05/ownership.xml…